Risk Assessment of Non-Metastatic Breast Cancer in the Genomic Era
Underwriting breast cancer in 2017 will require an understanding of the current and growing role of genomics in the assessment of its mortality risk. This is not to lessen the importance of well-known prognosticators such as tumor/node/metastasis (TNM) staging, estrogen receptor/progesterone receptor (ER/PR) and human epidermal receptor growth factor 2 (HER2) receptor status, grade, or the mitotic activity index (MAI). Rather, it is to keep abreast of additional genomics-based prognostic tools that can be used to further stratify breast cancer and its risks.
Underwriting Presentations from the Spring 2017 WAHLU Meeting
The following presentations from the April 27, 2017 Wisconsin Association of Health and Life Underwriters Meeting have been posted at the WAHLU site:
- Underwriting around the World by Al Klein
- Autoimmune Disease: Triggers and Treatments by Anne Sherman
- NT-proBNP and Some Other Stuff by Hank George
InsurTech for U.S. Life Insurance has Arrived
After three visits to Silicon Valley in three months I’ve come to the conclusion that InsurTech for the U.S. life insurance market has arrived. And the Genie isn’t going back into the bottle. U.S. InsurTech financing hit $1.377 billion in 2015, with the global figure about double that (CB Insights). No slowdown occurred in 2016.
Article begins on page 4.
Big Data, Big Insight – What Does It Offer to Life Insurers?
In an earlier Risk Insights article, we examined the bold claim for big data that the abundance and speed of information would make knowledge redundant. We concluded that if knowledge is understood as the body of causal explanations for observed statistical correlations, there could indeed be a grain of truth in such a claim, especially in the field of commercial applications.
Cervical Screening and HPV Testing
Understanding the association between persistent cervical infection with high-risk human papillomavirus (HPV) and the development of cervical cancer is fundamental when underwriting cases where HPV is present. This article explores the latest research and relationship.
Underwriter Focus: Why Insurers Should Give Weight to the Global Rise in Eating Disorders
The magnitude of the cost, both to the individual and the economy as a whole, represented by eating disorders is often underestimated. The growing numbers presenting to services in high income countries is not merely a reflection of service availability, but a very real increase in the number of cases.
The Potential - and Reality - of Blockchain
One of the hottest topics in financial services these days is blockchain. First introduced as the technology behind the currency Bitcoin, its value and potential are now recognized much more broadly. While not everyone fully understands it, more and more people are talking about it.
Deals, Drivers & Disruptors (LOMA Resource)
A new U.S. president, low interest rates, and embattled regulations are among the many challenges insurer must successfully navigate today—and for the foreseeable future.